Literature DB >> 8665245

Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma.

S Hill1, J M Thomas.   

Abstract

Between October 1988 and November 1994, 100 patients with cutaneous metastases from malignant melanoma were treated by carbon dioxide laser ablation under local or general anaesthesia as appropriate. There were minimal postoperative complications and most wounds healed within 6 weeks. A total of 34 of the 53 patients in this series with stage IIIa disease were controlled with four or fewer laser ablations during the first year from presentation. This technique provides a simple effective alternative to hyperthermic isolated limb perfusion with melphalan. Patients with disease not controlled by laser can be considered for isolated limb perfusion.

Entities:  

Mesh:

Year:  1996        PMID: 8665245     DOI: 10.1002/bjs.1800830425

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  2 in total

1.  Carbon dioxide laser ablation as first-line management of in-transit cutaneous malignant melanoma metastases.

Authors:  Nanda Kandamany; Peter Mahaffey
Journal:  Lasers Med Sci       Date:  2008-06-20       Impact factor: 3.161

2.  Application of CO2 laser evaporation in locally advanced melanoma.

Authors:  Otis M Vrielink; Schelto Kruijff; Barbara L van Leeuwen; Jan Ln Roodenburg
Journal:  Melanoma Manag       Date:  2019-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.